| Size | Price | |
|---|---|---|
| Other Sizes |
| Targets |
(S)-N-Boc-3-hydroxypyrrolidine does not target a specific protein or enzyme for pharmacological intervention. Its utility is as a chiral building block and chemical reagent for organic synthesis. The Boc protecting group and the chiral hydroxyl group make it a valuable intermediate for the preparation of enantiomerically enriched pharmaceutical compounds.
|
|---|---|
| ln Vitro |
The in vitro activity of (S)-N-Boc-3-hydroxypyrrolidine is its function as a chiral building block and chemical reagent for organic synthesis and drug discovery. The compound's chiral nature makes it valuable for the synthesis of enantiomerically pure pharmaceutical compounds. The hydroxyl group provides a handle for further functionalization, while the Boc group protects the amine during synthetic transformations.
|
| ln Vivo |
No significant in vivo activity has been reported for (S)-N-Boc-3-hydroxypyrrolidine as a therapeutic agent. The compound is primarily utilized as a chemical reagent and chiral building block rather than a pharmacologically active compound.
|
| Enzyme Assay |
In vitro enzyme/receptor binding assays are not typically performed for (S)-N-Boc-3-hydroxypyrrolidine, as it functions as a chemical building block rather than a drug candidate. The compound is used in organic synthesis reactions where it serves as a precursor for the preparation of more complex chiral molecules.
|
| Cell Assay |
For in vitro cellular experiments, (S)-N-Boc-3-hydroxypyrrolidine is not typically used in cell-based assays. The compound is primarily used as a chemical intermediate in organic synthesis.
|
| Animal Protocol |
In vivo animal experiments with (S)-N-Boc-3-hydroxypyrrolidine are not commonly performed, as the compound is primarily used as a chemical building block rather than a therapeutic candidate.
|
| ADME/Pharmacokinetics |
Pharmacokinetic properties of (S)-N-Boc-3-hydroxypyrrolidine have not been characterized, as it is a research-use chemical intermediate rather than a drug candidate. The compound has a molecular weight of 187.24 g/mol and a melting point of 47-52°C. It should be stored at room temperature in continental US.
|
| Toxicity/Toxicokinetics |
The compound is intended for research use only and not for human therapeutic or diagnostic applications. Standard laboratory safety precautions should be observed when handling this chemical reagent.
|
| Additional Infomation |
(S)-N-Boc-3-hydroxypyrrolidine is a chiral compound commonly used in organic synthesis as a chiral building block and as a sulfonylation reagent for organic synthesis and drug discovery. The compound has no clinical or therapeutic applications.
|
| Molecular Formula |
C9H17NO3
|
|---|---|
| Molecular Weight |
187.24
|
| Exact Mass |
187.12
|
| CAS # |
101469-92-5
|
| PubChem CID |
854055
|
| Appearance |
White to off-white solid powder
|
| Density |
1.1±0.1 g/cm3
|
| Boiling Point |
273.3±33.0 °C at 760 mmHg
|
| Melting Point |
60-64 °C(lit.)
|
| Flash Point |
119.1±25.4 °C
|
| Vapour Pressure |
0.0±1.3 mmHg at 25°C
|
| Index of Refraction |
1.502
|
| LogP |
-0.08
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
2
|
| Heavy Atom Count |
13
|
| Complexity |
198
|
| Defined Atom Stereocenter Count |
1
|
| SMILES |
CC(C)(C)OC(=O)N1CC[C@@H](C1)O
|
| InChi Key |
APCBTRDHCDOPNY-ZETCQYMHSA-N
|
| InChi Code |
InChI=1S/C9H17NO3/c1-9(2,3)13-8(12)10-5-4-7(11)6-10/h7,11H,4-6H2,1-3H3/t7-/m0/s1
|
| Chemical Name |
tert-butyl (3S)-3-hydroxypyrrolidine-1-carboxylate
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 5.3407 mL | 26.7037 mL | 53.4074 mL | |
| 5 mM | 1.0681 mL | 5.3407 mL | 10.6815 mL | |
| 10 mM | 0.5341 mL | 2.6704 mL | 5.3407 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
